APPLICATION
ANDA040455
TYPE
ANDA
ORIGINAL APPROVAL
2003-03-03
LATEST ACTION
2020-09-28
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
NOREPINEPHRINE BITARTRATEPrescription
NOREPINEPHRINE BITARTRATE EQ 1MG BASE/ML · INJECTABLE · INJECTION
Approval history
2020-09-28Labeling · Supplement 22 · standardAP
2015-08-31Manufacturing (CMC) · Supplement 18 · unknownAP
2003-03-03OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.